Medical Department, Research Unit, University Hospital of North-Norway Harstad, St. Olavs gt. 70, Harstad, Norway.
UIT Arctic University of Norway, Tromsø, Norway.
BMC Gastroenterol. 2023 Oct 23;23(1):363. doi: 10.1186/s12876-023-02979-x.
Fecal microbiota transplantation (FMT) has become an important treatment method in recurrent Clostridioides difficile infections and is under investigation as a treatment for several other diseases. FMT's mechanism of action is assumed to be through alterations of the colon microbiota. FMT can be delivered by several methods, but few studies have directly compared how FMT is distributed in the colon by different methods. Specifically, the proximal distribution of FMT delivered by enema is unknown.
In eight participants, we administered contrast fluid (CF) with viscosity similar to an FMT in a crossover study design. First, CF was administered by colonoscopy, followed by an abdominal X-ray to visualize the CF distribution. Next, after four to eight weeks, participants were given CF, but as an enema, followed by a positioning procedure. X-rays were obtained before (enema ÷) and after (enema +) the positioning procedure.
Proportion of participants with CF in cecum were 100% after colonoscopy, 50% after enema + and 38% after enema ÷. In the transverse colon, proportions were 100% (colonoscopy), 88% (enema +) and 63% (enema ÷). There were no adverse events.
This study shows proof of concept for the distribution of FMT to proximal colon when delivered by enema. A positioning procedure after the enema slightly improves the proximal distribution. However, colonoscopy is the only method that ensures delivery to the cecum. Studies are needed to see if FMT colon distribution correlates with treatment effectiveness.
The study was retrospectively registered at ClinicalTrials.gov (NCT05121285) (16/11/2021).
粪便微生物群移植(FMT)已成为复发性艰难梭菌感染的重要治疗方法,并正在作为多种其他疾病的治疗方法进行研究。FMT 的作用机制被认为是通过改变结肠微生物群。FMT 可以通过多种方法进行,但很少有研究直接比较不同方法的 FMT 在结肠中的分布情况。具体来说,灌肠法输送的 FMT 在结肠近端的分布情况尚不清楚。
在一项交叉研究设计中,我们在八名参与者中使用与 FMT 粘度相似的对比液(CF)进行了研究。首先,通过结肠镜检查给予 CF,然后进行腹部 X 光检查以显示 CF 的分布。接下来,在四到八周后,参与者给予 CF,但作为灌肠剂,然后进行定位程序。在定位程序前后(灌肠÷)进行 X 光检查。
结肠镜检查后 CF 进入盲肠的参与者比例为 100%,灌肠+后为 50%,灌肠÷后为 38%。在横结肠中,比例分别为 100%(结肠镜检查)、88%(灌肠+)和 63%(灌肠÷)。没有发生不良事件。
这项研究证明了通过灌肠将 FMT 输送到结肠近端的概念。灌肠后进行定位程序可略微改善近端分布。然而,结肠镜检查是确保将 FMT 输送至盲肠的唯一方法。需要进一步研究以确定 FMT 结肠分布是否与治疗效果相关。
该研究在 ClinicalTrials.gov (NCT05121285)(2021 年 11 月 16 日)进行了回顾性注册。